Allworth Financial’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,000
| Closed | -$1.82K | – | 4665 |
|
|
2025
Q1 | $1.82K | Hold |
1,000
| – | – | ﹤0.01% | 3237 |
|
|
2024
Q4 | $1.53K | Hold |
1,000
| – | – | ﹤0.01% | 3245 |
|
|
2024
Q3 | $2.01K | Hold |
1,000
| – | – | ﹤0.01% | 2968 |
|
|
2024
Q2 | $2.14K | Hold |
1,000
| – | – | ﹤0.01% | 2893 |
|
|
2024
Q1 | $2.87K | Hold |
1,000
| – | – | ﹤0.01% | 2663 |
|
|
2023
Q4 | $1.77K | Hold |
1,000
| – | – | ﹤0.01% | 2723 |
|
|
2023
Q3 | $3.16K | Hold |
1,000
| – | – | ﹤0.01% | 2331 |
|
|
2023
Q2 | $661 | Hold |
1,000
| – | – | ﹤0.01% | 2840 |
|
|
2023
Q1 | $798 | Hold |
1,000
| – | – | ﹤0.01% | 2749 |
|
|
2022
Q4 | $2.26K | Hold |
1,000
| – | – | ﹤0.01% | 2198 |
|
|
2022
Q3 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 2235 |
|
|
2022
Q2 | $4K | Buy |
+1,000
| New | +$4K | ﹤0.01% | 1846 |
|